Anti-Human Factor XII Aptamer(Cat#: CTMM-0124-TT34)
This product is an aptamer which binds to the Human Factor XII with an affinity of 1-50 nM.
Specific Inquiry 
Specifications
| Target Category |
Protein |
| Target |
F12 |
| Alternative Names |
Coagulation Factor XII; Plasma Coagulation Factor XIIa; Hageman Factor; HAF; Coagulation Factor XII (Hageman Factor); Coagulation Factor XIIa Heavy Chain; Coagulation Factor XIIa Light Chain; Beta-Factor XIIa Part 1; Beta-Factor XIIa Part 2; HAE3; HAEX |
| Gene ID |
2161 |
| UniProt ID |
P00748 |
| Target Overview |
This gene encodes coagulation factor XII which circulates in blood as a zymogen. This single chain zymogen is converted to a two-chain serine protease with an heavy chain (alpha-factor XIIa) and a light chain. The heavy chain contains two fibronectin-type domains, two epidermal growth factor (EGF)-like domains, a kringle domain and a proline-rich domain, whereas the light chain contains only a catalytic domain. On activation, further cleavages takes place in the heavy chain, resulting in the production of beta-factor XIIa light chain and the alpha-factor XIIa light chain becomes beta-factor XIIa heavy chain. Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha-factor XIIa and then to beta-factor XIIa. The active factor XIIa participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin. It activates coagulation factors VII and XI. Defects in this gene do not cause any clinical symptoms and the sole effect is that whole-blood clotting time is prolonged. |
| Chemical Modification |
2'-fluoro pyrimidines |
| Type |
RNA |
| Species Reactivity |
Human |
| Length |
50-100 nt |
| Affinity (Kd) |
1-50 nM |
| Binding Conditions/Buffer |
20mM Hepes, 150mM NaCl, 2mM CaCl₂, with or without 0.01%BSA |
| GC Content |
60.00% |
| Molecular Weight |
24691.81 g/mole |
| nmoles/OD260 |
1.29 |
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
